Publicaciones en las que colabora con F. Xavier López Labrador (19)

2022

  1. Cytomegalovirus specific polyfunctional T-cell responses expressing CD107a predict control of CMV infection after liver transplantation

    Cellular Immunology, Vol. 371

2018

  1. Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk – an observational, retrospective study

    Transplant International, Vol. 31, Núm. 6, pp. 649-657

  2. Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance

    Journal of Clinical Virology, Vol. 102, pp. 77-83

2015

  1. Overcoming drug resistance in HSV, CMV, HBV and HCV infection

    Future Microbiology, Vol. 10, Núm. 11, pp. 1759-1766

2014

  1. Computational models of liver fibrosis progression for hepatitis C virus chronic infection

    BMC Bioinformatics, Vol. 15

2013

  1. Hepatitis C virus genetic association to rate of liver fibrosis progression

    2013 IEEE 3rd International Conference on Computational Advances in Bio and Medical Sciences, ICCABS 2013

2012

  1. Hepatitis C virus viral kinetics during α-2a or α-2b pegylated interferon plus ribavirin therapy in liver transplant recipients with different immunosuppression regimes

    Journal of Clinical Virology, Vol. 53, Núm. 3, pp. 231-238

  2. New developments in the management of hepatitis C virus infection: Focus on boceprevir

    Biologics: Targets and Therapy, Vol. 6, pp. 249-256

2011

  1. Boceprevir in the treatment of chronic hepatitis C virus infection

    Virus Adaptation and Treatment, Vol. 3, Núm. 1, pp. 7-17

  2. Genomic medicine reaches HCV-related liver transplantation: Hopes and clinical and public health implications

    Journal of Hepatology

2007

  1. Trends for genetic variation of Hepatitis C Virus quasispecies in Human Immunodeficiency virus-1 coinfected patients

    Virus Research, Vol. 130, Núm. 1-2, pp. 285-291

2006

  1. Genetic similarity of hepatitis C virus and fibrosis progression in chronic and recurrent infection after liver transplantation

    Journal of Viral Hepatitis, Vol. 13, Núm. 2, pp. 104-115

2004

  1. Genetic Variability of Hepatitis C Virus Non-Structural Protein 3 and Virus-Specific CD8+ Response in Patients with Chronic Hepatitis C

    Journal of Medical Virology, Vol. 72, Núm. 4, pp. 575-585

  2. Genetic variability of hepatitis C virus NS3 protein in human leukocyte antigen-A2 liver transplant recipients with recurrent hepatitis C

    Liver Transplantation, Vol. 10, Núm. 2, pp. 217-227

  3. The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8+ T cells in patients with chronic infection

    Journal of Immunological Methods, Vol. 287, Núm. 1-2, pp. 91-99

2003

  1. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis

    Liver Transplantation, Vol. 9, Núm. 3, pp. 228-235

2000

  1. Hepatitis C virus and the host: An imbalance induced by immunosuppression?

    Hepatology, Vol. 32, Núm. 2, pp. 433-435

1999

  1. Coinfección por el virus de la hepatitis C y el virus de la inmunodeficiencia humana: Implicaciones clínicas y biológicas

    Medicina Clinica, Vol. 113, Núm. 1, pp. 28-35

  2. Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, Núm. 10, pp. 5692-5697